期刊文献+

辛伐他汀对原发性高血压患者血、尿β_2-微球蛋白的影响 被引量:9

下载PDF
导出
摘要 目的观察羟甲戊二酰辅酶A还原酶抑制剂辛伐他汀(京必舒新)对原发性高血压患者血、尿β2-微球蛋白(β2-M)的影响。方法将200例原发性高血压患者随机分为两组,单纯降压组100例,给予常规降压治疗;联合治疗组100例在常规降压治疗基础上加辛伐他汀治疗,疗程均为6个月。分别检测治疗前后血β2-M、尿β2-M、血清总胆固醇和高密度脂蛋白胆固醇。结果治疗后联合治疗组血、尿β2-M较治疗前均下降(P<0.01);治疗后联合治疗组较单纯降压组血、尿β2-M下降(P分别为<0.01,<0.05),单纯降压组血、尿β2-M治疗前后比较差异有显著性;辛伐他汀组尿β2-M下降量与血清TC下降量呈正相关(r=0.368,P<0.05),尿β2-M的下降量与HDL-C上升呈负相关(r=-0.320,P<0.05)。治疗前两组患者尿β2M与TC呈无相关关系(r=0.158,P>0.05)。结论辛伐他汀可以降低血、尿β2-M,对高血压肾脏具有保护作用。
出处 《临床内科杂志》 CAS 2007年第1期52-53,共2页 Journal of Clinical Internal Medicine
基金 2002年中山市卫生局立项科研基金资助
  • 引文网络
  • 相关文献

参考文献3

二级参考文献10

  • 1杜志民,曾群英,董吁钢,胡承恒.脂必妥(60例)与辛伐他汀(30例)治疗高脂血症的比较[J].新药与临床,1997,16(1):63-64. 被引量:20
  • 2陆宗良 寇文容 等.Simvastatin治疗高脂血症的临床观察[J].中华心血管病杂志,1993,21(4):216-216.
  • 3Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines( Committee on the Management of Patients with Unstable Angina)[J].J Am Coll Cardiol,2000,36:970-1062.
  • 4Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the National Cholesterol Evaluation Program(NCEP)Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol(Adulta Treatment PanelIII) [J].JAMA,2001,285:2486-2497.
  • 5Pederson JR,Olsson AG,Faergeman V,et al.Lipoprotein changes andreduction in the incidence of major coronary heart diaease events in the Scandinavian Simvastatin Survival Study(4S) [J].Circulation,1998,97:1453-1460.
  • 6Flaker GC,Warnica JW,Sack FM,et al.For the Cholesterol and RecurrentEvent(CARE) investigators.Pravastatin prevents clinical events in revascularized patiens with average cholesterol concentrations[J].J Am Coll Cardiol,1999,34:106-112.
  • 7Corti R,Fayad ZA,Fuster V,et al.Effects of lipid-lowering bysimvastatin on human ahterosclerotic lesions[J].Circulation,2001,104:249-252.
  • 8Rauch U,osende JI,Chesebro JH,et al.Statin and cardiovasculardiseases: the multiple effects of lipid-lowering therapy by statins[J].Atherosclerosis,2000,153:181-189.
  • 9杨进刚,胡大一,刘坤申,李田昌,彭建军,商丽华.冠状动脉造影患者中肾动脉狭窄的发生率[J].中华内科杂志,2002,41(1):24-27. 被引量:48
  • 10邢惠莉,沈卫峰,张奇,张瑞岩,张建盛.冠心病患者的肾动脉狭窄及介入治疗[J].介入放射学杂志,2002,11(4):266-268. 被引量:23

共引文献13

同被引文献39

引证文献9

二级引证文献37

;
使用帮助 返回顶部